Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
3,920,951
-
Shares change
-
+42,740
-
Total reported value, excl. options
-
$61,377,705
-
Value change
-
+$427,571
-
Put/Call ratio
-
5.74%
-
Number of buys
-
21
-
Number of sells
-
-30
-
Price
-
$15.65
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2020
75 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2020.
XBiotech Inc. - Common Shares, no par value (XBIT) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,920,951 shares
of 33,289,095 outstanding shares and own 11.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,304,011 shares), VANGUARD GROUP INC (732,179 shares), NORTHERN TRUST CORP (282,925 shares), STATE STREET CORP (274,910 shares), GEODE CAPITAL MANAGEMENT, LLC (240,387 shares), CAAS CAPITAL MANAGEMENT LP (138,316 shares), WELLS FARGO & COMPANY/MN (114,135 shares), Nuveen Asset Management, LLC (82,555 shares), AQR CAPITAL MANAGEMENT LLC (61,086 shares), and ALPS ADVISORS INC (52,398 shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.